Akram Al Makki, MD
Associate Professor of Medicine Practice
FACP, FASN
- aalmakki@iu.edu
- Address
-
IUH Arnett Nephrology
915 Mezzanine Drive, Suite A
Lafayette, IN 47904 - PubMed:
-
Bio
Dr. Akram Al-Makki is a nephrologist practicing at Indiana University Health – Arnett in Lafayette, Indiana, USA. He received his medical degree from Damascus University Faculty of Medicine in 1992. He is board certified by the American Board of Internal Medicine in the specialty of Internal Medicine and the subspecialty of Nephrology. He is also affiliated with Indiana University School of Medicine and Purdue University College of Pharmacy. He has passion for medical research and medical education. He has been the Director of Graduate Medical Education at IU Health Arnett since 2012. He received multiple awards and recognitions for his involvement in teaching and patient care like the Trustee Teaching Award from Indiana University School of Medicine (IUSM), Outstanding Preceptor Award, The Indiana University Health West Central Region’s (WCR) Values Leadership Award (VLA) and The AC Arnett Award. He lectured nationally and internationally on topics related to chronic kidney disease as well as other areas in clinical nephrology and hypertension. He was a member of a team of nephrologists who developed a simplified approach to emergency dialysis using novel treatment approach via stand-alone blood pump powered by car battery for treatment of acute renal failure in field hospitals in Syria. This modality helped save many patients with acute renal failure whether caused by shock due to hemorrhage or by crush injury. He authored and coauthored multiple peer reviewed papers published in different esteemed journals and presented in national and international medical meetings.
Key Publications
• Al-Makki A, Taber T. Neutropenic fever in COVID-19 in kidney transplant patient. Rev Med Virol. 2020 Aug 28:e2156. doi: 10.1002/rmv.2156. Epub ahead of print. PMID: 32856324.
• Sekkarie M, Murad L, Al-Makki A, Al-Saghir F, Rifai O, Isreb M. End-Stage Kidney Disease in Areas of Armed Conflicts: Challenges and Solutions. Semin Nephrol. 2020 Jul;40(4):354-362. doi: 10.1016/j.semnephrol.2020.06.003. PMID: 32800286.
• Al-Makki A, Frost K, Yun SA, Overholser B, Shepler B. Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study. J Pharm Pharm Sci. 2019;22(1):593-598. doi: 10.18433/jpps30581. PMID: 31804923.
• Schuster A, Al-Makki A, Shepler B. Use of Paricalcitol as Adjunctive Therapy to Renin-Angiotensin-Aldosterone System Inhibition for Diabetic Nephropathy: A Systematic Review of the Literature. Clin Ther. 2019 Nov;41(11):2416-2423. doi: 10.1016/j.clinthera.2019.09.009. Epub 2019 Oct 7. PMID: 31601446.
• Isreb M, Al-Makki A, Buatois E. Canagliflozin and Renal Outcomes in Diabetic Nephropathy. N Engl J Med. 2019 Sep 12;381(11):1088. doi: 10.1056/NEJMc1909687. PMID: 31509682.
• Sutton JM, Ash SR, Al Makki A, Kalakeche R. A Daily Hospital Progress Note that Increases Physician Usability of the Electronic Health Record by Facilitating a Problem-Oriented Approach to the Patient and Reducing Physician Clerical Burden. Perm J. 2019;23:18-221. doi: 10.7812/TPP/18-221. Epub 2019 Jun 14. PMID: 31314721; PMCID: PMC6636503.
• Yeboah KA, Allspaw A, Al-Makki A, Shepler BM. Hydralazine-associated Amenorrhea in a Premenopausal Patient With Chronic Kidney Disease: A Case Report and Review of Literature. Clin Ther. 2018 Sep;40(9):1592-1595. doi: 10.1016/j.clinthera.2018.07.022. Epub 2018 Aug 27. PMID: 30166053.
• Kim S, Al-Makki A and Shepler B. A Review of Extended-Release Calcifediol in Patients with Chronic Kidney Disease Stage 3 and 4 and in Healthy Patients. J Nephrol Kidney Dis. 2018; 2(1): 1015.
• Albright T, Al-Makki A, Kalakeche R, Shepler B. A Review of Ferric Pyrophosphate Citrate (Triferic) Use in Hemodialysis Patients. Clin Ther. 2016 Oct;38(10):2318-2323. doi: 10.1016/j.clinthera.2016.08.012. Epub 2016 Sep 28. PMID: 27692637.
• Agarwal AK, Ash SR; Principal Investigators of the CentrosFLO Trial. Maintenance of blood flow rate on dialysis with self-centering CentrosFLO catheter: A multicenter prospective study. Hemodial Int. 2016 Oct;20(4):501-509. doi: 10.1111/hdi.12443. Epub 2016 Jun 27. PMID: 27346562. (Principal Investigators of the CentrosFLO Trial include: A Al-Makki)
• Carson C, Al-Makki A, Shepler B. Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function? J Pharm Pharm Sci. 2016;19(1):1-7. doi: 10.18433/J3K020. PMID: 27096690.
• Isreb MA, Rifai AO, Murad LB, Al-Makki A, Al-Saghir F, Sekkarie MA. Care and outcomes of end-stage kidney disease patients in times of armed conflict: recommendations for action. Clin Nephrol. 2016 May;85(5):281-8. doi: 10.5414/CN108795. PMID: 27007869.
• Sekkarie MA, Zanabli AR, Rifai AO, Murad LB, Al-Makki AA. The Syrian conflict: assessment of the ESRD system and response to hemodialysis needs during a humanitarian and medical crisis. Kidney Int. 2015 Feb;87(2):262-5. doi: 10.1038/ki.2014.336. PMID: 25635715.
• Rifai AO, Murad LB, Sekkarie MA, Al-Makki AA, Zanabli AR, Kayal AA, Soudan KA. Continuous venovenous hemofiltration using a stand-alone blood pump for acute kidney injury in field hospitals in Syria. Kidney Int. 2015 Feb;87(2):254-61. doi: 10.1038/ki.2014.334. PMID: 25635714.
• Bousher A, Al-Makki A, Sutton J, Shepler B. A review of sucroferric oxyhydroxide for the treatment of hyperphosphatemia in patients receiving dialysis. Clin Ther. 2014 Dec 1;36(12):2082-2093. doi: 10.1016/j.clinthera.2014.09.021. Epub 2014 Oct 29. PMID: 25450474
• Al-Makki A, Rifai AO, Murad L, Zanabli AR, Kayal A, Soudan K, Kherallah M, Alsaghir F, Sekkarie M. The syrian national kidney foundation: Response for the need of kidney patients during the crisis. Avicenna J Med. 2014 Jul;4(3):54-7. doi: 10.4103/2231-0770.133331. PMID: 24982825; PMCID: PMC4065460.
• Ghafoor A, Almakki A. Renal confined sarcoidosis: Natural history and diagnostic challenge. Avicenna J Med. 2014 Apr;4(2):44-7. doi: 10.4103/2231-0770.130346. PMID: 24761384; PMCID: PMC3994709.
• Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE, Zabaneh RI, Tong-Starksen S, Mayo MR, Tang H, Polu KR, Duliege AM, Fishbane S; PEARL Study Groups. Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. N Engl J Med. 2013 Jan 24;368(4):320-32. doi: 10.1056/NEJMoa1203166. PMID: 23343062. (PEARL Study Groups include: A Al-Makki)
• Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med. 2011 Apr;39(4):613-20. doi: 10.1097/CCM.0b013e318206b5a2. PMID: 21200319. (AZEPTIC Trial Investigators include: A Al-Makki)
• Lacson EK Jr, Al-Makki A, Caplan E, Zigel C. An unexpected clue: the peripheral blood smear in a patient with AIDS. Md Med J. 1996 Jun;45(6):482-4. PMID: 8999269.
• The Clinician’s Illustrated Dictionary in Hypertension (thesis in Arabic). M. Jundi, A. Almakki, et al. Published as a textbook in Arabic in Damascus, Syria in 1992
Abstracts
• T-Shaped Peritoneal Dialysis Catheter With Twin Coils, The Maxflow (abstract). S. Ash, A. Almakki, K. Brown, et al. Seminars in Dialysis, Volume 21, Issue 1, JAN 2008. page 111
• Pica in hemodialysis patients, is it a problem (abstract). A. Almakki, et al. JASN, Volume 9, Sep. 1998
Posters Presentations
• Hypoxia Inducible Factor (HIF) Stabilizers in the Management of Anemia of Chronic Kidney Disease: A Systematic Review of Phase 3 Clinical Trials. Sarah Lamon PharmD Candidate, Akram Al-Makki MD, FACP, FASN, Trexie Rudd PharmD, Brian Shepler PharmD. Purdue University, West Lafayette, IN. A poster presentation submitted in 2020 to American Society of Health-Systems Pharmacists (ASHP) for the Midyear Clinical Meeting
• Should paricalcitol be used as adjunctive therapy to RAAS inhibition for diabetic nephropathy? A review of the literature. Alexandra Schuster, PharmD Candidate, Akram Al-Makki, MD, and Brian Shepler, PharmD. A poster presentation/abstract accepted for presentation at the American Society of Health-Systems Pharmacists (ASHP) Midyear Clinical Meeting in Anaheim, CA in December of 2018
• Ergocalciferol versus cholecalciferol in non-dialysis dependent chronic kidney disease patients: a retrospective cohort study. Sang-A Yun, Akram Al-Makki, Brian Overholser, Brian M Shepler. Poster presented at the National Kidney Foundation's 2018 Spring Clinical Meetings in Austin, Texas, April 10-14, 2018. Poster 177. Abstract published in AJKD in April 2018. Volume 71, Issue 4, 336
• Care and Outcome of Refugees Kidney Transplant Patients in Jordan. Kamel Hatahet, Mohamed A. Sekkarie, Majd Isreb, Akram Almakki, Fahd Alsaghir, Saleh Kaysi, Lina Murad, Sami Alasfar. A poster presentation/abstract at American Society of Nephrology (ASN) Kidney Week 2017. TH-PO975
• Processes of Care and Outcomes of End Stage Renal Disease Hemodialysis Patients during a Man Made Disaster. Majd Isreb, Lina Murad, Akram Almakki, Mohamad Alhosaini, Kamel Hatahet, Mohamed A. Sekkarie. A poster presentation/abstract at American Society of Nephrology (ASN) Kidney Week 2016. TH-PO1062
• PSYCHOSOCIAL IMPACT OF WAR ON SYRIAN REFUGEES WITH ESRD. Majd Isreb, Hisham Al Kukhun, Saif Aldeen Al-Adwan, Taha Kass-Hout, Lina Murad, A Oussama Rifai, Fahd Al-Saghir, Akram Al-Makki, Mohamed Sekkarie. A poster presentation/abstract at National Kidney Foundation (NKF) 2016 Spring Clinical Meeting. Poster Number: 235
• Unexpected Chest X-ray in a patient with CHF. AL-Makki A, et al. Case Report Poster. Presented at Maryland chapter meeting of ACP. First Prize Winner: poster competition. Baltimore, MD. May 1996
| Year | Degree | Institution |
|---|---|---|
| 1992 | MD | Damascus University |
Renal diseases
EMR
Pharmacy
Medical education
CKD
AKI
Desc: Volunteer and Adjunct Faculty Teaching Award
Scope: School
Date: 2022-09-01
Desc: Trustee Teaching Award
Scope: University
Date: 2020-05-01
Desc: • Trustee Teaching Award from Indiana University School of Medicine (IUSM) in 2020: The Indiana University Board of Trustees established this award to recognize outstanding teaching and to emphasize the primacy of learning and of learners in the medical school. This award acknowledges and applauds the vital role the physician plays as a medical educator
Scope: University
Date:
Desc: • Outstanding Preceptor Award from 3rd year medical students/class of 2020/IUSM-WL in 2019
Scope: Campus
Date:
Desc: • Outstanding Preceptor Award from 3rd year medical students/class of 2019/IUSM-WL in 2018
Scope: Campus
Date:
Desc: • The Indiana University Health West Central Region’s (WCR) Values Leadership Award (VLA) in 2017: The Indiana University Health Values Leadership Award program recognizes individuals who demonstrate extraordinary dedication to IU Health’s mission and seven values while at work, in their community and throughout their daily lives. It is the highest physician award at WCR
Scope: Regional
Date:
Desc: • The AC Arnett Award at Indiana University Health Arnett in 2015: AC Arnett Award is a West Central Region award for outstanding achievement in helping the region move forward, making exceptional contributions to the health and well-being of the community and contribution to the overall success of the organization. It is the highest physician award at Arnett Clinic for those who demonstrate values of professionalism, education, research and compassionate care
Scope: Local
Date:
Desc: • Fellow of American Society of Nephrology (FASN) in 2004: The designation FASN honors members of the Society who have distinguished themselves through excellence in practice or research. FASN status represents recognition by the Society of outstanding credentials, high professional achievement, commitment to the field, and demonstrated scholarship
Scope: National
Date:
Desc: • Certificate of Appreciation. Granted By: Indiana University School of Medicine/ West Lafayette in 2013
Scope: Campus
Date:
Desc: • Fellow of American College of Physicians (FACP) in 2001 and inducted in 2002: Being an FACP® is a distinction earned from colleagues who recognize my accomplishments and achievements over and above the standard practice of medicine. The most important considerations for ACP Fellowship are excellence and contributions made to both medicine and to the broader community in which the internist lives and practices
Scope: National
Date: